Firms

SPRIM Global Investments

SPRIM Global Investments

Singapore · New York, United States

sprim.net

SPRIM Global Investments (SGI), identified in issuer financing announcements as SPRIM Global Investments Pte. Ltd., is a privately held Singapore-based life-sciences investment firm. It backs clinical-stage biotechnology, medical devices, healthcare software and pharmaceutical R&D services, using equity and structured financing together with clinical operating expertise. Its public team includes core investment partners, venture partners, TrialCap clinical-trial finance specialists and group operational staff. The own directory dates the investment firm to2008, while a founder biography describes deployment of its current investing strategies from2015; these source chronologies are kept distinct from the SPRIM consulting business established in2001. SGI is distinguished from SPRIM PRO consulting/CRO services, portfolio operating companies and individual fund vehicles. Its clinical-stage portfolio includes auditory science, neurodevelopmental precision medicine, epilepsy monitoring, neuromodulation and blood-brain-barrier research. Announced financing capacity and joint ventures are not automatically completed LP fund raises.

Founded
—
Type
Venture capital

Funds1

  • TKS1$50M

    Historical joint SPRIM Ventures/Tikehau healthcare venture fund. Own SGI publication confirms actual USD50M initial closing, with subsequent USD75M an unachieved target in that article. Tikehau regulatory report confirms initial close announced March2018 and later closing August23,2019; EUR55M at year-end2019 is an AUM snapshot, not substituted as initial cashraise. Exact initial closing day undisclosed, announcedAtNULL. This fund’s joint Tikehau legal management is distinguished from SGI’s current PteLtd direct-equity buyer.

Team

Operations and support

Adele HosseiniAdele HosseiniVenture Director
Al HummelAl HummelSenior Partner
Amudhan ArumugamAmudhan ArumugamIT Manager
Chang Chu ChuenChang Chu ChuenSenior Investment Analyst
Chong Wee KhooChong Wee KhooDirector of Accounting & Compliance
Daniel MartinezDaniel MartinezVP Clinical Trials Financing
Elizabeth WangElizabeth WangTrialCap, Director, Credit Structuring
Gonzalo RubioGonzalo RubioTrialCap, Partner
Guillaume PfeferGuillaume PfeferVenture Partner
Hartini IsmailHartini IsmailGroup HR Manager
Igor MatushanskyIgor MatushanskyVenture Partner
Ivan JarryIvan JarryCo-Founder, Managing Partner
Janice WongJanice WongAccountant
Joti MarangoJoti MarangoVenture Partner
Juan PalazónJuan PalazónFinancial Controller
Maddy HoangMaddy HoangInvestment Analyst
Michael ShleiferMichael ShleiferCo-Founder, Managing Partner
Nick SrikanthNick SrikanthVenture Partner
Shamini ChandranShamini ChandranAdministrative Assistant
Sylvain LabattuSylvain LabattuManaging Director, TrialCap
Thomas FratacciThomas FratacciPartner, Group CFO

Co-investing

aMoon
ARIS Occitanie
Flerie
Shionogi
Sofilaro

Investments